Rational Investing

	Total Market Capitalization of All Firms	$944,550 mm
	Average Market Capitalization	$37,782 mm
	Average Market to Model Ratio Weighted by Log of Market Cap	1.0
	Standard Deviation of MM Ratio	0.4
	Average Beta	0.8
	Average EV To Revenue	9.5
	Average EV To EBITDAM	25.3
	Average Price To Free Cash Flow	40.6

Ticker	Company Name	Market To Model	Market Cap ($ mm)	EV to Revenue	Price To FCF	EV/EBITDAM	% Growth	Beta	As Of
CRL	Charles River Laboratories Hol	1.99	17,653	5.9	99	33.3	15	1.1	Mar 21
JAZZ	Jazz Pharmaceuticals plc	1.69	10,605	4.9	19.9	16.7	11	1.0	Mar 21
PRAH	PRA Health Sciences Inc	1.66	10,893	3.2	40.4	26.5	20	1.3	Mar 21
EVT.DE	Evotec SE	1.65	7,209	12.2	36.3	40	10	0.7	Mar 21
GNS.L	Genus Plc	1.38	4,919	8.6	53.4	40	7	0.6	Dec 20
LONN.SW	Lonza Group AG	1.31	54,974	11.2	71.1	40	16	0.7	Dec 20
MRNA	Mdrna Inc	1.27	83,072	67.7	99	40	70	0.8	Dec 20
MEDP	Medpace Holdings Inc	1.18	6,454	6.2	44.4	35.3	12	1.3	Mar 21
UCB.BR	UCB SA	1.04	19,673	3.8	22.4	11.5	13	0.7	Dec 20
BIIB	Biogen Idec	0.97	61,148	4.8	9.8	10.1	6	0.7	Mar 21
AMGN	Amgen Inc	0.96	138,576	6.5	15.7	14.3	3	0.7	Mar 21
CSL.AX	CSL Ltd.	0.93	104,212	10.6	59.9	36.1	13	0.7	Dec 20
GILD	Gilead Sciences Inc	0.88	85,805	4.3	19.8	8.7	9	0.5	Mar 21
GMAB.CO	Genmab A/S	0.75	28,820	3.6	45.7	49.0	49	1.0	Mar 21
ILMN	Illumina Inc.	0.75	66,012	16.3	50.0	41.3	28	0.9	Mar 21
ALXN	Alexion Pharmaceuticals Inc	0.73	40,148	6.1	12.9	10.1	16	1.2	Mar 21
RGEN	Repligen Corporation	0.73	10,056	16.5	99	43.6	70	0.9	Mar 21
HALO	Halozyme Therapeutics Inc	0.72	6,213	10.9	19.5	15.7	141	1.4	Mar 21
ALKS	Alkermes, Inc.	0.64	3,966	3.9	24.7	26.3	4	1.0	Mar 21
QIA.DE	Qiagen NV	0.63	13,268	5.7	28.5	11.8	42	0.5	Mar 21
REGN	Regeneron Pharmaceuticals Inc	0.63	56,962	5.5	15.4	12.9	27	0.4	Mar 21
VRTX	Vertex Pharmaceuticals Inc.	0.63	50,523	7.1	21.3	13.6	15	0.7	Mar 21
QGEN	Qiagen Nv	0.60	10,946	4.8	33.3	13.0	42	0.5	Mar 21
INCY	Incyte Corp.	0.50	18,171	5.7	11.4	9.0	20	0.8	Mar 21
068270.KS	Celltrion Inc.	0.47	34,270	0.3	61.6	33.9	47	0.8	Dec 20